--- title: "Akzo Nobel Earnings Call Signals Margin-Led Momentum" type: "News" locale: "en" url: "https://longbridge.com/en/news/293537310.md" description: "Akzo Nobel reported Q2 earnings with a cautiously upbeat tone, highlighting margin expansion and strong cash flow despite modest organic growth. Adjusted gross margin rose to 42.7%, marking five consecutive quarters of improvement. The company reiterated its 2026 EBITDA target of at least EUR 1.47 billion. Key developments include progress on the Axalta merger, achieving sustainability goals early, and managing inflation risks. While decorative paint volumes weakened, coatings and specialty segments showed resilience." datetime: "2026-07-23T00:25:56.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293537310.md) - [en](https://longbridge.com/en/news/293537310.md) - [zh-HK](https://longbridge.com/zh-HK/news/293537310.md) --- # Akzo Nobel Earnings Call Signals Margin-Led Momentum Akzo Nobel ((AKZOY)) has held its Q2 earnings call. Read on for the main highlights of the call. ### Claim 55% Off TipRanks - Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions - Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Akzo Nobel’s latest earnings call struck a cautiously upbeat tone, as management highlighted another quarter of margin expansion, solid cash generation and a major sustainability milestone, despite modest organic growth and reported revenue decline. Executives acknowledged pockets of weakness in decorative paints and marine projects, but argued that disciplined pricing, working capital discipline and the Axalta merger pipeline more than offset current headwinds. ## Organic Growth and Pricing Discipline Organic sales in the second quarter rose 2% year on year, driven by a 3% price increase with volumes broadly stable. Management stressed that pricing actions are firmly aimed at protecting margins as inflation risk returns, signaling that price discipline remains a core lever while demand stays mixed. ## Margins Extend Winning Streak Adjusted gross margin climbed to 42.7%, up 70 basis points, and adjusted EBITDA margin reached 15.4%, up 40 basis points. This marked the fifth consecutive quarter of year on year margin expansion, underscoring the success of cost and pricing programs even as mix and regional demand remain uneven. ## Profitability and Long-Term EBITDA Ambitions Adjusted EBITDA came in at EUR 398 million, up 5% at comparable scope and in constant currencies once the India disposal is excluded. Management reiterated its 2026 adjusted EBITDA ambition of at least EUR 1,470 million, framing current progress as a step on a multi‑year profitability journey. ## Cash Flow Strength and Working Capital Efficiency Free cash flow reached EUR 108 million in the quarter, supported by sharper management of receivables and inventories. Trade working capital fell to 15.6% of revenue, a 140 basis point improvement year on year, helping lift return on investment to 13.8% and reinforcing the balance sheet. ## Capital Structure and Leverage To support the special dividend tied to the Axalta transaction, Akzo Nobel issued a EUR 750 million bond in June. Net leverage stands at 2.2 times, a level management appears comfortable with as it balances shareholder returns, merger funding and ongoing investment. ## Operational Performance Across Segments Coatings volumes rose 2%, with powder coatings delivering mid‑single‑digit growth on architectural demand and Asia momentum. Automotive and Specialty volumes also grew mid‑single digits with aerospace especially strong, while the Refinish business returned to growth after previous softness. ## Sustainability Milestone Achieved Early The company reported a 50% reduction in Scope 1 and 2 carbon emissions, reaching this target four years ahead of schedule. Management framed this as evidence of sustainability leadership that should support customer relationships and regulatory preparedness, while also implying long‑term cost and efficiency benefits. ## Axalta Merger and Synergy Roadmap The planned merger with Axalta is progressing, with a shareholder vote set for early August and closing aimed for late 2026 or early 2027. Akzo Nobel has identified more than $600 million of cost synergies, with about 90% targeted within three years, and expects 100–200 basis points of revenue synergies on top. ## Reported Revenue Decline and Portfolio Changes Total reported revenue declined 1% in the quarter, a drop partly linked to the sale of liquid businesses in India that shaved around 3% off sales. A modest foreign exchange translation headwind also weighed on reported numbers, masking underlying organic growth and margin gains. ## Decorative Paint Volume Weakness Decorative paint volumes fell 4%, mainly in EMEA where a softer do‑it‑yourself season in Western Europe hurt demand. China also dragged on Deco volumes as a weak real estate market dampened construction and renovation activity, leaving this segment a clear soft spot. ## Negative Mix Effects Group mix reduced growth by about 1%, reflecting a shift toward lower‑margin products and segments. In Coatings, mix was a negative 2% largely due to lower packaging volumes, trimming the benefit from both price increases and volume gains elsewhere. ## Marine and Protective Project Delays Marine volumes declined in the quarter, while Protective Coatings faced project delays in the Middle East and disruptions from ships stuck at sea. Management cautioned that project timing and tender cycles remain unpredictable, which could keep these businesses volatile in the near term. ## Inflation Risk in Raw Materials and Logistics Akzo Nobel warned that raw material and logistics inflation is resurfacing, with a mid‑teens cost headwind expected in the second half. While pricing rose 3% in the quarter and is set to increase further, management acknowledged that volatility may pressure margins near term as price actions lag cost spikes. ## Russia Exposure and Operational Uncertainty The company has deconsolidated its Russian entities after they were placed under state administration in mid‑July. Net assets in Russia were reported at EUR 214 million with a larger foreign exchange exposure, though management stressed that the market represents less than 2% of group sales, limiting the financial impact. ## Cash Flow vs. Expectations and One-Off Costs Despite positive free cash flow, analysts noted that the Q2 figure was below consensus and down year on year. Management maintained that the full‑year cash flow trajectory is unchanged, but flagged identified cash outs, including significant merger‑related costs, as a temporary drag. ## Litigation and Regulatory Uncertainties The timing of the Ichthys arbitration remains unresolved, with a judgment now only expected several years out. Regulatory reviews of the Axalta merger in major jurisdictions are ongoing, and management guided that more clarity on approvals and conditions should emerge after the summer. ## Forward Guidance and Outlook Management reaffirmed its 2026 adjusted EBITDA target of at least EUR 1,470 million, supported by a EUR 100 million step‑up driven mainly by industrial excellence savings. For the near term, it guided Q3 adjusted EBITDA around EUR 390 million with flat volumes, mid‑single‑digit pricing to offset mid‑teens raw material inflation, tighter working capital and slightly lower capex near EUR 300 million. Akzo Nobel’s earnings call painted a picture of a company quietly rebuilding quality of earnings through pricing power, cost efficiency and balance‑sheet discipline, even as top‑line conditions remain patchy. With sustainability gains banked and Axalta synergies on the horizon, investors are being asked to look through near‑term volume and inflation noise to a more profitable, scale‑enhanced coatings group. ### Related Stocks - [AXTA.US](https://longbridge.com/en/quote/AXTA.US.md) ## Related News & Research - [AXTA: Record Q2 results with margin gains, robust cash flow, and progress on the AkzoNobel merger](https://longbridge.com/en/news/294050377.md) - [Akzo Nobel Q2 2026 Results Show Margin Gains Amid Revenue Pressure and Axalta Merger Plans](https://longbridge.com/en/news/293502616.md) - [AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress](https://longbridge.com/en/news/293502785.md) - [Akzo Nobel Files Q2 2026 Report, Flags Risks Around Proposed Axalta Deal](https://longbridge.com/en/news/293503588.md) - [Axalta Q2 sales and adjusted EPS beat estimates on acquisitions](https://longbridge.com/en/news/294046791.md)